M&A Deal Summary |
|
|---|---|
| Date | 2022-03-30 |
| Target | Oranim Pharm |
| Sector | E-Commerce |
| Buyer(s) | IM Cannabis |
| Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
| Category | Company |
|---|---|
| Sector | Consumer Products |
| Revenue | 54M USD (2022) |
IM Cannabis is an international cannabis company providing premium products to medical patients and adult-use recreational consumers. The ecosystem created through its international operations leverages the Company's unique data-driven perspective and product supply chain globally. With its commitment to responsible growth and financial prudence, and the ability to operate within the strictest regulatory environments, the Company has quickly become one of the leading cultivators and distributors of high-quality cannabis globally. IM Cannabis is based in Vancouver, British Columbia.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector (E-Commerce) | 1 of 1 |
| Type (Add-on Acquisition) | 2 of 2 |
| Country (Israel) | 1 of 1 |
| Year (2022) | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-04-01 |
MYM
Vancouver, British Columbia, Canada MYM is focuses on developing high-end organic medicinal cannabis supplements and topical products. MYM also has an interest in the development of high-density farming facilities and technologies that allow MYM to expand its brand into the global market. MYM was founded in 2014 and is based in Vancouver, Canada. |
Buy | - |
